Bardy Diagnostics Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- Bardy Diagnostics's estimated annual revenue is currently $20.8M per year.
- Bardy Diagnostics received $Undisclosed in venture funding in July 2018.
- Bardy Diagnostics's estimated revenue per employee is $234,079
- Bardy Diagnostics's total funding is $35M.
- Bardy Diagnostics has 89 Employees.
- Bardy Diagnostics grew their employee count by 46% last year.
- Bardy Diagnostics currently has 2 job openings.
|Liz Mynhier||Sr. Director of Clinical Services & Customer Experience|
|James Landis||Sales Director|
|Ken Nelson||Chief Commercial Officer|
|Brit Baird||Senior Director of Regulatory Affairs and Quality Assurance|
|Jonathan Wu||Director of Strategic Marketing|
|Gust Bardy||Chairman/Chief Executive Officer & Chief Medical Officer|
|Chuck Dulken||VP Engineering|
|MARK HANDFELT||Chief Operating Officer|
|BOBBY COCKRILL||vp Sales|
|Philip Porreca||VP of IT|
What Is Bardy Diagnostics?
Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Bardy Dx was founded to address the long-standing complaint in cardiac arrhythmia monitoring that traditional monitors were large, bulky, uncomfortable, and typically recorded noisy QRS signals. Our goal: to completely redesign an arrhythmia monitor with optimal signal detection, comfort, and ease of use. CAM is the first P-wave centric ECG monitor - a single-patient use monitor that records continuously for up to 7 days. This focus on the P-wave is a major new tool for cardiologists and cardiac rhythm specialists for accurately diagnosing arrhythmias.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Young Dental Ca...||$11M||47||15%||N/A|
|Kestra Medical ...||$13.6M||58||38%||N/A|
Bardy Diagnostics News
SEATTLE, Sept. 6, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc. Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring ...
The clearance was received by Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data ...
August 15, 2019 — Bardy Diagnostics Inc. announced that HealthTech Arkansas, a healthcare accelerator and investment fund that connects early-stage ...
Bardy Diagnostics Funding
|2018-07-19||$Undisclosed||Undisclosed||SV Health Investors||Article|
Bardy Diagnostics Executive Hires
|2018-04-03||Ken Nelson||Chief Commercial Officer||Article|